MLchartDataset catalogue

autologous dendritic cell vaccine ACT2001

Term · Oncology and biomedicine · MLC-T-ONC-011599

A cell-based cancer vaccine composed of autologous, immature dendritic cells (DCs), with potential immunostimulating and antineoplastic activities. Upon leukapheresis, immature DCs are isolated and re-administered intra-tumorally. The immature DCs internalize and process the tumor-associated antigens (TAAs), migrate to the lymphatic system, and then expose the immune system to the TAAs. This induces a specific cytotoxic T-lymphocyte (CTL) response against the cancer cells leading to tumor cell lysis.

Table 1. Record
IdentifierMLC-T-ONC-011599
FieldOncology and biomedicine
Synonymsautologous DC vaccine ACT2001
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011599",
  "term": "autologous dendritic cell vaccine ACT2001",
  "field": "Oncology and biomedicine",
  "definition": "A cell-based cancer vaccine composed of autologous, immature dendritic cells (DCs), with potential immunostimulating and antineoplastic activities. Upon leukapheresis, immature DCs are isolated and re-administered intra-tumorally. The immature DCs internalize and process the tumor-associated antigens (TAAs), migrate to the lymphatic system, and then expose the immune system to the TAAs. This induces a specific cytotoxic T-lymphocyte (CTL) response against the cancer cells leading to tumor cell lysis.",
  "synonyms": [
    "autologous DC vaccine ACT2001"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-dendritic-cell-vaccine-act2001/"
}

Record 2,933 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.